乙酰唑胺
医学
耐受性
安慰剂
恶心
不利影响
呕吐
麻醉
食欲不振
随机对照试验
内科学
病理
替代医学
作者
Martin ten Hove,Deborah I. Friedman,Anil D. Patel,Isabella Irrcher,Michael Wall,Michael McDermott
标识
DOI：10.1097/wno.0000000000000322
摘要
Acetazolamide appears to have an acceptable safety profile at dosages up to 4 g/d in the treatment of idiopathic intracranial hypertension. The majority of participants in the Idiopathic Intracranial Hypertension Treatment Trial were able to tolerate acetazolamide above 1 g/d for 6 months.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
伯克利芙蓉王
学霸业
Criminology34
mmmm
无极微光
kaio_escolar
yanaiqi
锅包肉
果果123
忧心的曼凝
arniu2008
DIVINEDC
GingerF
端庄问蕊
红伞伞白杆杆
ahj
Rita
supshuo
路戳戳
核桃
皖公网安备34019202002308
